• 1
    Shepard C.W., Finelli L., Alter M.J. (2005) Global epidemiology of hepatitis C virus infection. Lancet Infect Dis 5: 55867.
  • 2
    Alberti A., Benvegnù L., Boccato S., Ferrari A., Sebastiani G. (2004) Natural history of initially mild chronic hepatitis C. Dig Liver Dis 36: 64654.
  • 3
    Davis G.L., Alter M.J., El-Serag H., Poynard T., Jennings L.W. (2010) Aging of hepatitis C virus (HCV)-infected persons in the United States: a multiple cohort model of HCV prevalence and disease progression. Gastroenterology 138: 51321.
  • 4
    Armstrong G.L., Wasley A., Simard E.P., McQuillan G.M., Kuhnert W.L., Alter M.J. (2006) The prevalence of hepatitis C virus infection in the United States, 1999 through 2002. Ann Intern Med 144: 70514.
  • 5
    Poynard T., Ratziu V., Charlotte F., Goodman Z., McHutchison J., Albrecht J. (2001) Rates and risk factors of liver fibrosis progression in patients with chronic hepatitis C. J Hepatol 34: 7309.
  • 6
    Massard J., Ratziu V., Thabut D., Moussalli J., Lebray P., Benhamou Y., Poynard T. (2006) Natural history and predictors of disease severity in chronic hepatitis C. J Hepatol 44: S1924.
  • 7
    Di Martino V., Lebray P., Myers R.P., Pannier E., Paradis V., Charlotte F., Moussalli J., Thabut D., Buffet C., Poynard T. (2004) Progression of liver fibrosis in women infected with hepatitis C: long-term benefit of estrogen exposure. Hepatology 40: 142633.
  • 8
    Shimizu I., Yasuda M., Mizobuchi Y., Ma Y.R., Liu F., Shiba M., Horie T., Ito S. (1998) Suppressive effect of oestradiol on chemical hepatocarcinogenesis in rats. Gut 42: 1129.
  • 9
    Yasuda M., Shimizu I., Shiba M., Ito S. (1999) Suppressive effects of estradiol on dimethylnitrosamine-induced fibrosis of the liver in rats. Hepatology 29: 71927.
  • 10
    Wang C.C., Krantz E., Klarquist J., Krows M., McBride L., Scott E.P., Shaw-Stiffel T., Weston S.J., Thiede H., Wald A., Rosen H.R. (2007) Acute hepatitis C in a contemporary US cohort: modes of acquisition and factors influencing viral clearance. J Infect Dis 196: 147482.
  • 11
    Hall J.M., Couse J.F., Korach K.S. (2001) The multifaceted mechanisms of estradiol and estrogen receptor signaling. J Biol Chem 276: 36,86972.
  • 12
    Gustafsson J.A. (2003) What pharmacologists can learn from recent advances in estrogen signaling. Trends Pharmacol Sci 24: 47985.
  • 13
    Revankar C.M., Cimino D.F., Sklar L.A., Arterburn J.B., Prossnitz E.R. (2005) A transmembrane intracellular estrogen receptor mediates rapid cell signaling. Science 307: 162530.
  • 14
    Thomas P., Pang Y., Filardo E.J., Dong J. (2005) Identity of an estrogen membrane receptor coupled to a G protein in human breast cancer cells. Endocrinology 146: 62432.
  • 15
    Maggiolini M., Picard D. (2010) The unfolding stories of GPR30, a new membrane-bound estrogen receptor. J Endocrinol 204: 10514.
  • 16
    Blight K.J., McKeating J.A., Rice C.M. (2002) Highly permissive cell lines for subgenomic and genomic hepatitis C virus RNA replication. J Virol 76: 1300114.
  • 17
    Lindenbach B.D., Evans M.J., Syder A.J., Wolk B., Tellinghuisen T.L., Liu C.C., Maruyama T., Hynes R.O., Burton D.R., McKeating J.A., Rice C.M. (2005) Complete replication of hepatitis C virus in cell culture. Science 309: 6236.
  • 18
    Bungyoku Y., Shoji I., Makine T., Adachi T., Hayashida K., Nagano-Fujii M., Ide Y.H., Deng L., Hotta H. (2009) Efficient production of infectious hepatitis C virus with adaptive mutations in cultured hepatoma cells. J Gen Virol 90: 168191.
  • 19
    Deng L., Adachi T., Kitayama K., Bungyoku Y., Kitazawa S., Ishido S., Shoji I., Hotta H. (2008) Hepatitis C virus infection induces apoptosis through a Bax-triggered, mitochondrion-mediated, caspase 3-dependent pathway. J Virol 82: 10,37585.
  • 20
    Stauffer S.R., Coletta C.J., Tedesco R., Nishiguchi G., Carlson K., Sun J., Katzenellenbogen B.S., Katzenellenbogen J.A. (2000) Pyrazole ligands: structure-affinity/activity relationships and estrogen receptor-alpha-selective agonists. J Med Chem 43: 493447.
  • 21
    Meyers M.J., Sun J., Carlson K.E., Marriner G.A., Katzenellenbogen B.S., Katzenellenbogen J.A. (2001) Estrogen receptor-beta potency-selective ligands: structure-activity relationship studies of diarylpropionitriles and their acetylene and polar analogues. J Med Chem 44: 423051.
  • 22
    Bologa C.G., Revankar C.M., Young S.M., Edwards B.S., Arterburn J.B., Kiselyov A.S., Parker M.A., Tkachenko S.E., Savchuck N.P., Sklar L.A., Oprea T.I., Prossnitz E.R. (2006) Virtual and biomolecular screening converge on a selective agonist for GPR30. Nat Chem Biol 2: 20712.
  • 23
    Kasai D., Adachi T., Deng L., Nagano-Fujii M., Sada K., Ikeda M., Kato N., Ide Y.H., Shoji I., Hotta H. (2009) HCV replication suppresses cellular glucose uptake through down-regulation of cell surface expression of glucose transporters. J Hepatol 50: 88394.
  • 24
    Liu Y., Shimizu I., Omoya T., Ito S., Gu X.S., Zuo J. (2002) Protective effect of estradiol on hepatocytic oxidative damage. World J Gastroenterol 8: 3636.
  • 25
    Lu G., Shimizu I., Cui X., Itonaga M., Tamaki K., Fukuno H., Inoue H., Honda H., Ito S. (2004) Antioxidant and antiapoptotic activities of idoxifene and estradiol in hepatic fibrosis in rats. Life Sci 74: 897907.
  • 26
    Inoue H., Shimizu I., Lu G., Itonaga M., Cui X., Okamura Y., Shono M., Honda H., Inoue S., Muramatsu M., Ito S. (2003) Idoxifene and estradiol enhance antiapoptotic activity through estrogen receptor-beta in cultured rat hepatocytes. Dig Dis Sci 48: 57080.
  • 27
    Cooke P.S., Heine P.A., Taylor J.A., Lubahn D.B. (2001) The role of estrogen and estrogen receptor-alpha in male adipose tissue. Mol Cell Endocrinol 178: 14754.
  • 28
    Miyanari Y., Atsuzawa K., Usuda N., Watashi K., Hishiki T., Zayas M., Bartenschlager R., Wakita T., Hijikata M., Shimotohno K. (2007) The lipid droplet is an important organelle for hepatitis C virus production. Nat Cell Biol 9: 108997.
  • 29
    Watashi K., Inoue D., Hijikata M., Goto K., Aly H.H., Shimotohno K. (2007) Anti-hepatitis C virus activity of tamoxifen reveals the functional association of estrogen receptor with viral RNA polymerase NS5B. J Biol Chem 282: 32,76572.